| MEDCX | VGAVX | MEDCX / VGAVX | |
| Total Expense Ratio | 1.82 | 0.20 | 910% |
| Annual Report Gross Expense Ratio | 1.83 | 0.20 | 915% |
| Fund Existence | 24 years | 13 years | - |
| Gain YTD | 0.910 | 0.369 | 247% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.52B | 6.76B | 111% |
| Annual Yield % from dividends | 4.13 | 5.30 | 78% |
| Returns for 1 year | 6.82 | 6.37 | 107% |
| Returns for 3 years | 25.03 | 26.42 | 95% |
| Returns for 5 years | 7.58 | 8.92 | 85% |
| Returns for 10 years | 28.35 | 35.66 | 79% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BAFAX | 45.58 | 0.66 | +1.47% |
| Brown Advisory Flexible Equity Adv | |||
| LZUOX | 18.33 | 0.13 | +0.71% |
| Lazard US Equity Focus Open | |||
| GGKPX | 28.61 | -0.01 | -0.03% |
| Goldman Sachs Income Builder P | |||
| MVCGX | 30.65 | -0.09 | -0.29% |
| MFS Mid Cap Value R1 | |||
| MCSSX | 38.13 | -0.14 | -0.37% |
| NYLI WMC Enduring Capital Investor Class | |||